Literature DB >> 30084492

Technical Indicators to Evaluate the Degree of Large Clot Formation Inside the Membrane Fiber Bundle of an Oxygenator in an In Vitro Setup.

Andreas Kaesler1, Felix Hesselmann1, Mark O Zander1, Peter C Schlanstein1, Georg Wagner1, Philipp Bruners2, Thomas Schmitz-Rode1, Ulrich Steinseifer1,3, Jutta Arens1.   

Abstract

The most common technical complication during ECMO is clot formation. A large clot inside a membrane oxygenator reduces effective membrane surface area and therefore gas transfer capabilities, and restricts blood flow through the device, resulting in an increased membrane oxygenator pressure drop (dpMO). The reasons for thrombotic events are manifold and highly patient specific. Thrombus formation inside the oxygenator during ECMO is usually unpredictable and remains an unsolved problem. Clot sizes and positions are well documented in literature for the Maquet Quadrox-i Adult oxygenator based on CT data extracted from devices after patient treatment. Based on this data, the present study was designed to investigate the effects of large clots on purely technical parameters, for example, dpMO and gas transfer. Therefore, medical grade silicone was injected into the fiber bundle of the devices to replicate large clot positions and sizes. A total of six devices were tested in vitro with silicone clot volumes of 0, 30, 40, 50, 65, and 85 mL in accordance with ISO 7199. Gas transfer was measured by sampling blood pre and post device, as well as by sampling the exhaust gas at the devices' outlet at blood flow rates of 0.5, 2.5, and 5.0 L/min. Pre and post device pressure was monitored to calculate the dpMO at the different blood flow rates. The dpMO was found to be a reliable parameter to indicate a large clot only in already advanced "clotting stages." The CO2 concentration in the exhaust gas, however, was found to be sensitive to even small clot sizes and at low blood flows. Exhaust gas CO2 concentration can be monitored continuously and without any risks for the patient during ECMO therapy to provide additional information on the endurance of the oxygenator. This may help detect a clot formation and growth inside a membrane oxygenator during ECMO even if the increase in dpMO remains moderate.
© 2018 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Carbon dioxide monitoring; Continuous monitoring; Device exchange; Extracorporeal membrane oxygenation; Oxygenator thrombosis

Mesh:

Year:  2018        PMID: 30084492     DOI: 10.1111/aor.13343

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

1.  Effect of Hematocrit on the CO2 Removal Rate of Artificial Lungs.

Authors:  Alexandra G May; Katelin S Omecinski; Brian J Frankowski; William J Federspiel
Journal:  ASAIO J       Date:  2020 Nov/Dec       Impact factor: 2.872

2.  In-Vitro Visualization of Thrombus Growth in Artificial Lungs Using Real-Time X-Ray Imaging: A Feasibility Study.

Authors:  Andreas Kaesler; Freya Lilli Rudawski; Mark Oliver Zander; Felix Hesselmann; Isaac Pinar; Thomas Schmitz-Rode; Jutta Arens; Ulrich Steinseifer; Johanna Charlotte Clauser
Journal:  Cardiovasc Eng Technol       Date:  2021-09-16       Impact factor: 2.305

3.  Establishment and evaluation of a rat model of extracorporeal membrane oxygenation (ECMO) thrombosis using a 3D-printed mock-oxygenator.

Authors:  Nao Umei; Angela Lai; Jennifer Miller; Suji Shin; Kalliope Roberts; Saif Ai Qatarneh; Shingo Ichiba; Atsuhiro Sakamoto; Keith E Cook
Journal:  J Transl Med       Date:  2021-04-28       Impact factor: 5.531

4.  TPMS-based membrane lung with locally-modified permeabilities for optimal flow distribution.

Authors:  Sebastian Victor Jansen; Jutta Arens; Felix Hesselmann; Michael Halwes; Patrick Bongartz; Matthias Wessling; Christian Cornelissen; Thomas Schmitz-Rode; Ulrich Steinseifer
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

5.  Dynamic oxygenator blood volume during prolonged extracorporeal life support.

Authors:  Rik H J Hendrix; Eva R Kurniawati; Sanne F C Schins; Jos G Maessen; Patrick W Weerwind
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

Review 6.  Toward a Long-Term Artificial Lung.

Authors:  Jutta Arens; Oliver Grottke; Axel Haverich; Lars S Maier; Thomas Schmitz-Rode; Ulrich Steinseifer; H P Wendel; Rolf Rossaint
Journal:  ASAIO J       Date:  2020-08       Impact factor: 3.826

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.